LineaRx Secures New RNA Therapeutics Customers for Contract Research Services
October 1st, 2018
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
Category: Press Release
Applied DNA Expands Its Cannabis Tagging Portfolio to Address Large Growers
September 25th, 2018
Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines
September 20th, 2018
APDN Forms Subsidiary, LineaRx, to Develop DNA for Biotherapeutics
September 18th, 2018
APDN Executes New 2 Year Contract with the U.S. Defense Logistics Agency
September 11th, 2018
Applied DNA Announces $1.65 Million Private Placement of Secured Convertible Notes
September 4th, 2018
APDN Presenting Linear DNA for Gene Therapy at Boston Immuno-Oncology Summit
August 27th, 2018
Applied DNA Reports FY’18 Q3 Results
August 13th, 2018
Applied DNA Schedules Fiscal 2018 Third Quarter Financial Results Conference Call for Monday, August 13, 2018 at 4:30 PM ET
August 6th, 2018